Gainers
- NGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of its average volume over the last 100 days. The company's market cap stands at $57.8 million.
- TC BioPharm (Holdings) (NASDAQ:TCBP) stock increased by 11.24% to $0.58. At the close, TC BioPharm (Holdings)'s trading volume reached 265.9K shares. This is 294.2% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.
- Nemaura Medical (NASDAQ:NMRD) shares rose 8.08% to $0.26. The company's market cap stands at $7.3 million.
- Exagen (NASDAQ:XGN) stock moved upwards by 7.54% to $1.71. The market value of their outstanding shares is at $28.9 million.
- NanoVibronix (NASDAQ:NAOV) shares rose 6.92% to $1.39. The market value of their outstanding shares is at $6.3 million.
- Allarity Therapeutics (NASDAQ:ALLR) stock rose 6.0% to $0.53. The market value of their outstanding shares is at $2.2 million. As per the press release, Q3 earnings came out 4 days ago.
Losers
- Alzamend Neuro (NASDAQ:ALZN) shares decreased by 19.4% to $1.12 during Monday's after-market session. Alzamend Neuro's trading volume hit 2.7 million shares by close, accounting for 13294.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
- Gain Therapeutics (NASDAQ:GANX) shares fell 16.37% to $2.3. The company's market cap stands at $29.2 million. As per the news, the Q3 earnings report came out 4 days ago.
- Acutus Medical (NASDAQ:AFIB) shares declined by 16.04% to $0.29. Today's trading volume for this security ended up closing at 399.7K shares, which is 117.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
- AVITA Medical (NASDAQ:RCEL) shares declined by 11.2% to $11.11. The market value of their outstanding shares is at $283.8 million.
- Vicarious Surgical (NYSE:RBOT) stock decreased by 10.67% to $0.37. The company's market cap stands at $64.4 million.
- Forte Biosciences (NASDAQ:FBRX) shares declined by 9.77% to $0.44. The company's market cap stands at $15.9 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.